Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 (ASBPW)

CUSIP: 738920115

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / *W EXP 02/14/203
Total 13F shares
8,027,001
Total 13F value
$142,492
Share change
-323,358
SEC-reported price per share
$0.02
Number of holders
26
Value change
-$8,136
Number of buys
1
Number of sells
6

Security key

738920115

Report period

Q4 2025

Institutions

26

Top holders

10

ASBPW full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Aspire Biopharma Holdings, Inc. SEC filings Aspire Biopharma Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ASBPW - Aspire Biopharma Holdings, Inc. - *W EXP 02/14/203 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Lance Friedman
Disclosed value leader
Lance Friedman
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 3/4/5 13F Lead comparable stake: 4.5% 13D/G row: Lance Friedman Showing 1-6 of 15 holder rows.

Quick read

Lance Friedman leads the comparable SEC ownership view at 4.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lance Friedman's linked filing trail.
Comparable ownership Top 5
Lance Friedman 4.5%
Harraden Circle Investments, LLC 0.31%
Donald G. Fell 0.38%
Crewe Advisors LLC 15%
Procyon Advisors, LLC 9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Lance Friedman
13D/G
13D/G
4.5%
$1,037,706
2,207,886 shares
 -$782,315 06 May 2025
Harraden Circle Investments, LLC
13D/G
13D/G
0.31%
$70,500
150,000 shares
 $0 31 Mar 2025
Donald G. Fell
3/4/5
Director
3/4/5
0.38%
$7,800
20,000 shares
 — 04 Jun 2025
Crewe Advisors LLC
13F
Company
13F
15%
$167,566
813,427 shares
 — 30 Sep 2025
Procyon Advisors, LLC
13F
Company
13F
9%
$97,368
472,661 shares
 — 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
8.2%
$88,281
428,552 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
8,027,001
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
29
Q4 2025 holders
26
Holder diff
-3
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .